Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Cardiff Oncology News

    4,08 $ +2,26% +0,09 $
    In : 3,8148 € | 18:44:25 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2P4GU
    ISIN: US14147L1089
    US-Symbol: CRDF
    Typ: Aktie

    Cardiff Oncology News

    26.03.24 - PR Newswire
    Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?
    Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics? PR Newswire
    15.03.24 - PR Newswire
    Thinking about buying stock in Mind Medicine, Ocean Biomedical, Archer Aviation, Outlook Therapeutics, or Cardiff Oncology?
    Thinking about buying stock in Mind Medicine, Ocean Biomedical, Archer Aviation, Outlook Therapeutics, or Cardiff Oncology? PR Newswire
    14.03.24 - PR Newswire
    Thinking about buying stock in SoundHound AI, Kinross Gold, Nu Holdings, Cardiff Oncology, or Turtle Beach?
    Thinking about buying stock in SoundHound AI, Kinross Gold, Nu Holdings, Cardiff Oncology, or Turtle Beach? PR Newswire
    13.03.24 - PR Newswire
    Thinking about buying stock in ShiftPixy, Minim, Cardiff Oncology, Laird Superfood, or Tenon Medical?
    Thinking about buying stock in ShiftPixy, Minim, Cardiff Oncology, Laird Superfood, or Tenon Medical? PR Newswire
    11.03.24 - PR Newswire
    Thinking about buying stock in Recursion Pharmaceuticals, SoundHound AI, Cardiff Oncology, Mind Medicine, or Auddia?
    Thinking about buying stock in Recursion Pharmaceuticals, SoundHound AI, Cardiff Oncology, Mind Medicine, or Auddia? PR Newswire
    08.03.24 - PR Newswire
    Thinking about buying stock in SoundHound AI, Gulf Island Fabrication, Macy's, Rigetti Computing, or Cardiff Oncology?
    Thinking about buying stock in SoundHound AI, Gulf Island Fabrication, Macy's, Rigetti Computing, or Cardiff Oncology? PR Newswire
    17.01.24 - PR Newswire
    Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research
    Cardiff Oncology Announces Publication of Data from Phase 1b study in second-​line KRAS-​mutated mCRC in Clinical Cancer Research PR Newswire
    20.11.23 - PR Newswire
    Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference
    Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference PR Newswire
    02.11.23 - PR Newswire
    Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
    Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update PR Newswire
    26.10.23 - PR Newswire
    Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update
    Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update PR Newswire
    26.09.23 - PR Newswire
    Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
    Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-​Agent Activity from Onvansertib Monotherapy PR Newswire
    05.09.23 - PR Newswire
    Cardiff Oncology to Present at Upcoming Investor Conferences in September
    Cardiff Oncology to Present at Upcoming Investor Conferences in September PR Newswire
    09.08.23 - PR Newswire
    Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
    Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update PR Newswire
    07.08.23 - PR Newswire
    Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship
    Cardiff Oncology Announces New Lead Program in First-​Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship PR Newswire
    24.07.23 - PR Newswire
    Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
    20.06.23 - PR Newswire
    Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
    05.06.23 - PR Newswire
    Cardiff Oncology to Present at the Jefferies Healthcare Conference
    Cardiff Oncology to Present at the Jefferies Healthcare Conference PR Newswire
    04.05.23 - PR Newswire
    Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
    Cardiff Oncology Reports First-​Quarter 2023 Results and Provides Business Update PR Newswire
    28.03.23 - PR Newswire
    Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer
    Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer PR Newswire
    06.03.23 - PR Newswire
    Cardiff Oncology Formally Introduces Scientific Advisory Board
    Cardiff Oncology Formally Introduces Scientific Advisory Board PR Newswire

    Newssuche

    Videos

    08:40 Uhr +6,45%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »